This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) shed 1.06% to $1.86 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.98% to 25,169.50 and Dow Jones Industrial Average falling 1.87% to 49,918.78.
TherapeuticsMD Inc. closed 36.95% short of its 52-week high of $2.95, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) fell 0.21% to $224.95.
Trading volume (39,927) eclipsed its 50-day average volume of 31,433.
Data source: Dow Jones Market Data, FactSet. Data compiled June 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-10-26 1730ET

TXMD

TherapeuticsMD Inc. (TXMD) shares fell 1.06% to $1.86 on Wednesday, underperforming competitors like AbbVie during a broad market decline where the NASDAQ and Dow Jones dropped nearly 2%. The stock remains 36.95% below its 52-week high of $2.95. Trading volume exceeded the 50-day average, indicating heightened activity amidst the poor trading session.

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors